Regulation of insulin-like growth factor binding protein secretion by human granulosa luteal cells in a polycystic ovary-like environment  Susanne Greisen,

Slides:



Advertisements
Similar presentations
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Advertisements

A powerful new agonist: flooding the system with growth hormone
Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome  Li Chen, M.S., Wen.
Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells  Herbert Fluhr, M.D., Julia Spratte, B.S., Jens.
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome  Silvia Ajossa, M.D., Stefano Guerriero, M.D.,
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.
Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway  Tatsuo Nakahara, M.D., Akira Iwase, M.D., Ph.D.,
Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome  Elisabeth Lerchbaum,
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
MRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome.
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives  George Mastorakos,
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Ovarian morphology and function during growth hormone therapy of short girls born small for gestational age  Jeanette Tinggaard, M.D., Rikke Beck Jensen,
Metformin directly inhibits androgen production in human thecal cells
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic.
Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome 
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Effect of the oxytocin antagonist antocin and agonist decomoton on baboon luteal cell production and release of progesterone  M. Yusoff Dawood, M.D.,
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 
Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary.
Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome  Sana M.
Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary.
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
FSH receptor, KL1/2, P450, and PAPP genes in granulosa-lutein cells from in vitro fertilization patients show a different expression pattern depending.
Shilla Chatterjee-Chakrabarty, Ph. D. , Brian T. Miller, Ph. D
Action of mifepristone on the expression of insulin-like growth factor binding protein-1 mRNA and protein during the early luteal phase in the human oviduct 
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome  Dorte Glintborg, M.D., Ph.D.,
Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis  Maria Karamouti, M.D, Panagoula.
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic.
Ontogeny of the ovary in polycystic ovary syndrome
Pregnancy-associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels  Jane Alrø Bøtkjær, M.Sc., Janni.
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome  Madhavi Pusalkar, M.Sc., Pervin Meherji, M.D.,
Estrogen receptor β agonist diarylpropionitrile inhibits lipopolysaccharide-induced regulated on activation normal T cell expressed and secreted (RANTES)
Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome  Annie A. Guedikian, B.S.,
Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action  Vanita Aroda, M.D., Theodore.
Estrogens and androgens affect human luteal cell function
Padmasana Singh, Ph. D. , Amitabh Krishna, Ph. D
Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.
Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin  Xing Yan Liu, M.Sc., Yun.
Requirement of heart and neural crest derivatives–expressed transcript 2 during decidualization of human endometrial stromal cells in vitro  Hisayuu Shindoh,
Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: a comparison of pregnant and obese women  Suman Rice, Ph.D., Bijal Patel,
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity  Jean-Patrice Baillargeon, M.D.,
Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation  Sabine Roesner,
Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo.
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial 
Halvard Gjønnæss  Fertility and Sterility 
Increased secretion of amylin in women with polycystic ovary syndrome
Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone.
It's not over till the last glomerulus forms
Fleur R. Cattrall, M. B. B. S. , Beverley J. Vollenhoven, M. B. B. S
Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.
Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than.
Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women.
Effect of leptin on prolactin and insulin-like growth factor-I secretion by cultured rat endometrial stromal cells  Kamani H. Tennekoon, Ph.D., Thampoe.
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.
Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin  Elsy Velázquez M, M.D.,
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome  Carlos Moran, M.D., Raquel Huerta, M.D., Barbara-Ann.
Paolo Moghetti, M.D.  Fertility and Sterility 
Human sperm cells express CD44
Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome  Yuwen Wu, M.D., Jianhua Zhang,
Differential effects of insulin-like growth factor-I and gonadotropins on the proliferative activity of two subgroups of granulosa cells: cumulus oophorus.
Inappropriate gonadotropin secretion in polycystic ovary syndrome
Intrauterine microdialysis reveals cycle-dependent regulation of endometrial insulin-like growth factor binding protein-1 secretion by human chorionic.
A new era in ovulation induction
Volume 56, Issue 6, Pages (December 1999)
The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production  Antonio Pellicer, M.D., Carmela Albert,
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation 
Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M
Presentation transcript:

Regulation of insulin-like growth factor binding protein secretion by human granulosa luteal cells in a polycystic ovary-like environment  Susanne Greisen, Ph.D., Allan Flyvbjerg, D.M.Sc., Thomas Ledet, D.M.Sc., Per Ovesen, D.M.Sc.  Fertility and Sterility  Volume 78, Issue 1, Pages 162-168 (July 2002) DOI: 10.1016/S0015-0282(02)03147-3

FIGURE 1 Effects of insulin, LH, and elevated androgen (10−5 mol/L) on accumulation of IGFBP-1 through IGFBP-4 in granulosa luteal cell-conditioned medium containing A (10−6 mol/L) and analyzed by WLB. Control conditions in lane 1. Lane 2 shows the effect of insulin (400 μU/mL). Lane 3 illustrates the influence of LH (10 μg/L). Lane 4 shows the result of androgen (10−5 mol/L) addition. Lane 5 shows the result of the addition of the three hormones combined (insulin, 400 μU/mL; LH, 10 μg/L; and A, 10−5 mol/L). Greisen. Effect of PCOS-like environment on IGFBPs. Fertil Steril 2002. Fertility and Sterility 2002 78, 162-168DOI: (10.1016/S0015-0282(02)03147-3)

FIGURE 2 The effects of insulin, LH, and A on the accumulation of IGFBP-1 in granulosa luteal cell-conditioned medium. The light gray columns illustrate the inhibitory effect of insulin (100 μU/mL–800 μU/mL). The dark gray columns show the effect of LH (1 μg/L–10 μg/L), and the solid columns represent the inhibitory consequence of A (10−5 mol/L) on the IGFBP-1 release from human granulosa luteal cells. The striped column illustrates the inhibitory effect of the three hormones combined (insulin, 400 μU/mL; LH, 10 μg/L; and A, 10−5 mol/L). Each column is displayed as mean ± SEM of three independent experiments, with two replicates per trial. ∗IGFBP-1 production differs significantly from control (P<.01). Greisen. Effect of PCOS-like environment on IGFBPs. Fertil Steril 2002. Fertility and Sterility 2002 78, 162-168DOI: (10.1016/S0015-0282(02)03147-3)

FIGURE 3 The effects of insulin, LH, and A on the accumulation of IGFBP-2 in granulosa luteal cell-conditioned medium. The light gray columns illustrate the stimulatory effect of insulin (100 μU/mL–800 μU/mL). The solid columns represent the stimulatory consequence of A (10−5 mol/L) on the IGFBP-2 release from human granulosa luteal cells, and the dark gray columns show that LH (1 μg/L–10 μg/L) does not influence the accumulation in the medium. The striped column illustrates the inhibitory effect of the three hormones combined (insulin 400 μU/mL, LH 10 μg/L, and A 10−5 mol/L) Each column is displayed as mean ± SEM of three independent experiments with two replicates per trial. ∗IGFBP-1 production differs significantly from control (P<.01). Greisen. Effect of PCOS-like environment on IGFBPs. Fertil Steril 2002. Fertility and Sterility 2002 78, 162-168DOI: (10.1016/S0015-0282(02)03147-3)

FIGURE 4 Identification of IGFBP-1 through IGFBP-4 in granulosa luteal cell-conditioned medium containing A (10−6 mol/L) analyzed by Western ligand blotting. Basic conditions in lane 1. Lanes 2–4 represent the effect of insulin (100 μU/mL–800 μU/mL). Lane 5–6 illustrates the effect of LH (1 μg/L–10 μg/L). Greisen. Effect of PCOS-like environment on IGFBPs. Fertil Steril 2002. Fertility and Sterility 2002 78, 162-168DOI: (10.1016/S0015-0282(02)03147-3)